Japan, July 27 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'ANTI- IL2 RECEPTOR GAMMA ANTIGEN BINDING PROTEINS.' Other related details are as follows:
Application Number: JP,2025-171516
Category (FI): A61K31/5377,C07K16/28,C12N15/63@Z,C12N15/13,C12N5/10,C12N5/071,A61K39/395@N,A61P43/00,121,A61K45/00,A61K39/395@U,A61K39/395@D,A61P43/00,111,A61P37/06,A61P37/02,A61P29/00,101,A61P19/02,A61P3/10,A61K38/17,A61K47/68,A61K47/64,A61K38/20,A61K38/16,A61K38/13,A61K31/573,A61K31/436,A61K31/7056,A61K35/28
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 10, 2025
Publication Date: Feb. 3
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
